Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

P

Pirogov Russian National Research Medical University

Other

0

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

0

Indications↗

Distinct diseases across all programs

21

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

The Role of Hormonal and Metabolic Disorders in the Debelopment of Gestational Diabetes Mellitus

Active, not recruiting

Prolonged Compression Therapy Following Foam Sclerotherapy of Varicose Veins

Earlier

Jul 30, 2026TrialImmediate and Long-term Results of Carotid Endarterectomy and Stenting in the Acute Stage of Ischemic Stroke

Jul 25, 2026TrialEvaluation of Shoulder Access Safety Using the NewMan Compression Device

Jul 23, 2026TrialOutcomes and Treatment Strategy for Patients With COVID-19 and Concurrent Acute Surgical Conditions: a Single-center Retrospective/Prospective Observational Cohort Study Based on Real-world Data (RWD)

Jul 14, 2026TrialChoosing an Access for Endovascular Treatment of Femoral-popliteal Segment Occlusions

Sep 9, 2025TrialTianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders.

Dec 1, 2024TrialVenoactive Drug Treatment of Pelvic Venous Disorders

3 more events

Oct 21, 2024TrialTiming of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage

Apr 19, 2024TrialImmunotherapy of the Recent-onset Type 1 Diabetes in Adolescents With Repeated Courses of Rituximab

Apr 1, 2022TrialEndothelial Protection in Convalescent COVID-19 Patients

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)